Stay updated on Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    7 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent change in the webpage content.
    Difference
    0.1%
    Check dated 2024-06-13T21:18:51.000Z thumbnail image
  6. Check
    14 days ago
    Change Detected
    Summary
    The value 7 on the webpage has recently changed to 8, indicating a significant update in the study details of a Phase 3B clinical trial comparing the efficacy and safety of Abrocitinib with Dupilumab in adults with moderate to severe Atopic Dermatitis.
    Difference
    0.1%
    Check dated 2024-06-06T14:18:03.000Z thumbnail image
  7. Check
    29 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for the study, specifying the inclusion and exclusion criteria for participants. This change provides more specific information about the health conditions and prior treatments required for participation in the study.
    Difference
    9%
    Check dated 2024-05-22T19:44:56.000Z thumbnail image
  8. Check
    50 days ago
    Change Detected
    Summary
    The value 'Go to the classic website' has been updated to 'Site Map'. This change likely pertains to the type of intervention related to medical and healthcare publications and documentation on the webpage.
    Difference
    0.7%
    Check dated 2024-05-01T18:09:13.000Z thumbnail image

Stay in the know with updates to Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page.